AQ

Abu Qurayesh

Active Director Director DIN 10111392
DIN 10111392 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Abu Qurayesh

Data last updated:

Abu Qurayesh is a Director at Inmedism Healthcare Private Limited (since 2023). Inmedism Healthcare Private Limited reported revenue of ₹17.1 Lakh (FY 2025).

DIN 10111392
Primary Designation Director
First Appointment 11 Apr 2023
Oldest Company Age 3 yrs
Largest company Inmedism Healthcare Private Limited · ₹17.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Inmedism Healthcare Private Limited U86100DL2023PTC412325
Director11 Apr 20232023₹17.1 Lakh (FY 2025)Active

Board colleagues of Abu Qurayesh

NameDINCompanyDesignation
Nilufa Yeasmin11369191Inmedism Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Inmedism Healthcare Private Limited
Premium access

Shareholding and investment profile for Abu Qurayesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abu Qurayesh

Abu Qurayesh currently holds 1 directorship: Inmedism Healthcare Private Limited (Director, since 11 Apr 2023, revenue ₹17.1 Lakh (FY 2025)).

Abu Qurayesh was first appointed on 11 Apr 2023 as Director at Inmedism Healthcare Private Limited.

The current boards of Abu Qurayesh's companies include Nilufa Yeasmin (Inmedism Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available